Description
BCR::ABL p210 Detection rRT-PCR Kit | BCR::ABL p210 Detection Kit by rRT-PCR Method
The BCR::ABL p210 Detection rRT-PCR Kit is an advanced tool for the accurate and rapid detection of the BCR::ABL p210 gene in clinical samples. Utilizing Real-Time Reverse Transcription PCR (rRT-PCR) technology, this kit enables the identification of aberrations and mutations associated with hematologic malignancies such as Chronic Myeloid Leukemia (CML) with high sensitivity and specificity. The BCR::ABL p210 Detection rRT-PCR Kit from ap-rad is designed and manufactured for the rapid, sensitive, and specific detection of the BCR::ABL p210 fusion.
The t(9;22) BCR::ABL chromosomal translocation is observed in patients with Chronic Myeloid Leukemia (CML) and some cases of B-cell Acute Lymphoblastic Leukemia (Ph+ ALL). This fusion is located on the derivative chromosome 22q11 and produces a chimeric mRNA transcript that drives uncontrolled cell proliferation. Typically, e13-a2 or e14-a2 transcripts are produced, leading to the generation of a 210 kilodalton protein (p210).
Key Features of the Kit:
- High Sensitivity: Detects the lowest amount of target RNA in clinical samples.
- Fast and Reliable Results: Suitable for use in molecular diagnostic laboratories.
- Easy to Use: Includes all necessary materials for performing rRT-PCR without the need for additional equipment.
- Standard Quality: Manufactured according to international standards for molecular testing.
This kit is ideal for clinical research, patient treatment monitoring, and the timely diagnosis of BCR::ABL-related diseases, helping laboratories make more accurate treatment decisions with confidence and speed.
ap-rad, a provider of molecular diagnostic kits with the highest quality standards, is ready to collaborate with laboratories across the country.
